362 related articles for article (PubMed ID: 34439208)
1. Microbiota-Associated Metabolites and Related Immunoregulation in Colorectal Cancer.
Chen Y; Chen YX
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439208
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota-derived short-chain fatty acids and colorectal cancer: Ready for clinical translation?
Hou H; Chen D; Zhang K; Zhang W; Liu T; Wang S; Dai X; Wang B; Zhong W; Cao H
Cancer Lett; 2022 Feb; 526():225-235. PubMed ID: 34843863
[TBL] [Abstract][Full Text] [Related]
3. Microbial Metabolite Dysbiosis and Colorectal Cancer.
Niekamp P; Kim CH
Gut Liver; 2023 Mar; 17(2):190-203. PubMed ID: 36632785
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota-derived metabolites in CRC progression and causation.
Dalal N; Jalandra R; Bayal N; Yadav AK; Harshulika ; Sharma M; Makharia GK; Kumar P; Singh R; Solanki PR; Kumar A
J Cancer Res Clin Oncol; 2021 Nov; 147(11):3141-3155. PubMed ID: 34273006
[TBL] [Abstract][Full Text] [Related]
5. Gut Microbiota-Derived Metabolites in Colorectal Cancer: The Bad and the Challenges.
Zhang W; An Y; Qin X; Wu X; Wang X; Hou H; Song X; Liu T; Wang B; Huang X; Cao H
Front Oncol; 2021; 11():739648. PubMed ID: 34733783
[TBL] [Abstract][Full Text] [Related]
6. Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.
Coker OO; Liu C; Wu WKK; Wong SH; Jia W; Sung JJY; Yu J
Microbiome; 2022 Feb; 10(1):35. PubMed ID: 35189961
[TBL] [Abstract][Full Text] [Related]
7. Relationships of Gut Microbiota Composition, Short-Chain Fatty Acids and Polyamines with the Pathological Response to Neoadjuvant Radiochemotherapy in Colorectal Cancer Patients.
Sánchez-Alcoholado L; Laborda-Illanes A; Otero A; Ordóñez R; González-González A; Plaza-Andrades I; Ramos-Molina B; Gómez-Millán J; Queipo-Ortuño MI
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502456
[TBL] [Abstract][Full Text] [Related]
8. Microbial metabolites in colorectal tumorigenesis and cancer therapy.
Liu Y; Lau HC; Yu J
Gut Microbes; 2023; 15(1):2203968. PubMed ID: 37095682
[TBL] [Abstract][Full Text] [Related]
9. The gut microbiota, bacterial metabolites and colorectal cancer.
Louis P; Hold GL; Flint HJ
Nat Rev Microbiol; 2014 Oct; 12(10):661-72. PubMed ID: 25198138
[TBL] [Abstract][Full Text] [Related]
10. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.
van de Wouw M; Boehme M; Lyte JM; Wiley N; Strain C; O'Sullivan O; Clarke G; Stanton C; Dinan TG; Cryan JF
J Physiol; 2018 Oct; 596(20):4923-4944. PubMed ID: 30066368
[TBL] [Abstract][Full Text] [Related]
11. Immune System, Microbiota, and Microbial Metabolites: The Unresolved Triad in Colorectal Cancer Microenvironment.
Hanus M; Parada-Venegas D; Landskron G; Wielandt AM; Hurtado C; Alvarez K; Hermoso MA; López-Köstner F; De la Fuente M
Front Immunol; 2021; 12():612826. PubMed ID: 33841394
[TBL] [Abstract][Full Text] [Related]
12. Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism.
Gao J; Xu K; Liu H; Liu G; Bai M; Peng C; Li T; Yin Y
Front Cell Infect Microbiol; 2018; 8():13. PubMed ID: 29468141
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota and microbiota-derived metabolites in colorectal cancer: enemy or friend.
Wang X; Sun X; Chu J; Sun W; Yan S; Wang Y
World J Microbiol Biotechnol; 2023 Sep; 39(11):291. PubMed ID: 37653349
[TBL] [Abstract][Full Text] [Related]
14. Microbial Metabolites in Colorectal Cancer: Basic and Clinical Implications.
Peng Y; Nie Y; Yu J; Wong CC
Metabolites; 2021 Mar; 11(3):. PubMed ID: 33802045
[TBL] [Abstract][Full Text] [Related]
15. Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer.
Qu R; Zhang Y; Ma Y; Zhou X; Sun L; Jiang C; Zhang Z; Fu W
Adv Sci (Weinh); 2023 Aug; 10(23):e2205563. PubMed ID: 37263983
[TBL] [Abstract][Full Text] [Related]
16. Diet-mediated gut microbial community modulation and signature metabolites as potential biomarkers for early diagnosis, prognosis, prevention and stage-specific treatment of colorectal cancer.
John Kenneth M; Tsai HC; Fang CY; Hussain B; Chiu YC; Hsu BM
J Adv Res; 2023 Oct; 52():45-57. PubMed ID: 36596411
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory Effects of Microbiota-Derived Short-Chain Fatty Acids in Autoimmune Liver Diseases.
Zhang W; Mackay CR; Gershwin ME
J Immunol; 2023 Jun; 210(11):1629-1639. PubMed ID: 37186939
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota-derived metabolites and colorectal cancer: New insights and updates.
Mohseni AH; Taghinezhad-S S; Fu X
Microb Pathog; 2020 Dec; 149():104569. PubMed ID: 33075518
[TBL] [Abstract][Full Text] [Related]
19. Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation.
Gasaly N; de Vos P; Hermoso MA
Front Immunol; 2021; 12():658354. PubMed ID: 34122415
[TBL] [Abstract][Full Text] [Related]
20. The association of diet, gut microbiota and colorectal cancer: what we eat may imply what we get.
Yang J; Yu J
Protein Cell; 2018 May; 9(5):474-487. PubMed ID: 29713943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
